Congressional Ephedra Action Could Spring From Election Of Rep. Davis
This article was originally published in The Tan Sheet
Executive Summary
Congresswoman-elect Susan Davis (D-Calif.) could carry her state-level efforts to enact legislation requiring warning labels on ephedra-containing dietary supplements with her into the federal arena.
You may also be interested in...
California Ephedrine Alkaloid Supplement Labeling Bill Veto Unexpected
California legislation requiring more stringent labeling for ephedrine-alkaloid dietary supplements was vetoed Sept. 30 by Gov. Gray Davis (D). The move came as a surprise to industry and to the office of Assemblywoman Susan Davis (D), who sponsored the bill.
Senate Antitampering Bill Addresses Product Discounting Concerns - Leahy
Senate legislation language prohibiting tampering with product identification codes on consumer products contains "significant improvements" over a version introduced in the House, co-sponsor Sen. Patrick Leahy (D-Vt.) maintained on the Senate floor Feb. 24.
GBL Would Become A DEA Controlled Substance Under House Date Rape Bill
Gamma butyrolactone (GBL) would be classified as a controlled substance under the proposed Hillary J. Farias Date-Rape Prevention Drug Act. The bill (HR 2130), introduced June 10 by Rep. Fred Upton (R-Mich.), unanimously passed the House Commerce/ Health Subcommittee at a mark-up July 27. Senate companion legislation is being drafted; the House bill is expected to go before the full Commerce Committee in the next few weeks.